Literature DB >> 18781072

A volumetric magnetic resonance imaging study of entorhinal cortex volume in dementia with lewy bodies. A comparison with Alzheimer's disease and Parkinson's disease with and without dementia.

Eva R Kenny1, Emma J Burton, John T O'Brien.   

Abstract

AIMS: To investigate whether subjects with dementia with Lewy bodies (DLB), Alzheimer's disease (AD) and Parkinson's disease with dementia (PDD) have reduced entorhinal cortex (EC) volumes compared to controls and cognitively intact Parkinson's disease (PD) subjects.
METHODS: Volumes of the EC were measured on magnetic resonance imaging (MRI) scans of 144 individuals (aged over 65 years): 20 with DLB, 26 with AD, 30 with PDD, 31 with PD and 37 normal age-matched controls.
RESULTS: Total normalised EC volumes were significantly smaller in DLB, AD and PDD patients compared to controls, and in DLB and AD patients compared to PD patients (p < 0.001). The percentage volume reduction in EC volume in the dementia groups relative to controls was 19.9% in DLB, 21.9% in AD and 14.7% in PDD.
CONCLUSIONS: MRI measurements of the EC have shown that volumes are smaller in dementia subjects compared to controls and patients with non-dementia disorders. Further research is required to recognise those at risk of dementia and to differentiate between the dementias. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18781072     DOI: 10.1159/000153432

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

Review 1.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

Review 2.  Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.

Authors:  Ping Lei Pan; Hai Cun Shi; Jian Guo Zhong; Pei Rong Xiao; Yuan Shen; Li Juan Wu; Yuan Ying Song; Gui Xiang He; Hua Liang Li
Journal:  Neurol Sci       Date:  2012-11-27       Impact factor: 3.307

Review 3.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

4.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Authors:  Daniel Weintraub; Nicole Dietz; John E Duda; David A Wolk; Jimit Doshi; Sharon X Xie; Christos Davatzikos; Christopher M Clark; Andrew Siderowf
Journal:  Brain       Date:  2011-11-21       Impact factor: 13.501

Review 5.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

6.  Neurodegeneration across stages of cognitive decline in Parkinson disease.

Authors:  Daniel Weintraub; Jimit Doshi; Deepthi Koka; Christos Davatzikos; Andrew D Siderowf; John E Duda; David A Wolk; Paul J Moberg; Sharon X Xie; Christopher M Clark
Journal:  Arch Neurol       Date:  2011-12

7.  Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.

Authors:  Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Travis R Stoub; Christopher G Goetz; Leyla deToledo-Morrell
Journal:  Mov Disord       Date:  2012-03-12       Impact factor: 10.338

Review 8.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

Review 9.  Neuroimaging in aging and neurologic diseases.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Handb Clin Neurol       Date:  2019

10.  Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats.

Authors:  Zongya Zhao; Yanxiang Niu; Peiqi Chen; Yu Zhu; Liangliang Shi; Xuewei Zhao; Chang Wang; Yehong Zhang; Zhixian Gao; Wenshuai Jiang; Wu Ren; Renjun Gu; Yi Yu
Journal:  Neural Plast       Date:  2021-07-28       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.